Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × OTHER_GOV × Engerix-B × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 1

Interventions

Gemcitabine 4 Cisplatin 4 Rituximab 2 Fluorouracil 2 Everolimus 2 tislelizumab 1 phosphorylethanolamine 1 human papillomavirus vaccine, L1 type 16, 18 1 famitinib 1 dalpiciclib 1 Zinc Sulfate 1 Zinc 1 Vitamin B 6 1 Tamoxifen 1 Sunitinib 1 Sorafenib 1 Radiotherapy, Adjuvant 1 Pyridoxine 1 Proton Pump Inhibitors 1 Prednisone 1 Platelet Transfusion 1 Pemetrexed 1 Patient Portals 1 Paclitaxel 1 Oxaliplatin 1 Neoadjuvant Therapy 1 N-hydroxy-4-acetylaminostilbene 1 Metformin 1 Melphalan 1 Mannitol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01082861 2010-03-19

TANGO

National Institute for Public Health and the Environment (RIVM)

Phase 4 Terminated

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡